Pediatric oncology has a comprehensive program of consultation and care of pediatric and adult patients with various forms of histiocytosis, including Langerhans Cell Histiocytosis (LCH), Rosai-Dorfman Disease (RDD), Erdheim-Chester Disease (EDC), Juvenile Xanthogranulomatous Disease (JXD), Hemophagocytic Lymphohistiocytosis (HLH) and Histiocytic Sarcomas. In addition, research is being directed toward the development of antibody-targeted and small molecule approaches for the diagnosis and treatment of patients with these disorders.



